Accelerate Life-Science Growth in Australia

Australia pairs world-class biomedical expertise with a thriving advanced manufacturing base—underpinned by generous R&D incentives and a regulatory system trusted worldwide.

Flexible Partnership Models

Select the structure that aligns with your capital plan:

• Leasing – operating leases to suit your needs.

• Project Finance – milestone-based funding that scales with your pipeline.

• Rent-to-Own – build equity in critical facilities while you innovate.

Who We Serve

• Global and domestic pharmaceutical companies scaling clinical or commercial production.

• Public and private research institutes driving next-generation biologics.

• Leading universities advancing translational science and talent development.

Why Australia?

• World-renowned clusters—Melbourne Biomedical Precinct, Sydney’s Westmead & Macquarie Park, Brisbane’s Translational Research Institute, and Adelaide BioMed City—deliver dense supplier networks and collaboration opportunities.

• Up to 43.5 % refundable R&D tax offset for eligible activities accelerates your ROI.

• Highly skilled workforce recognised for precision engineering, GMP compliance, and digital-biotech integration.

• Trusted regulators—the Therapeutic Goods Administration (TGA) and PIC/S membership—ensure global-grade quality pathways.

• Strategic Indo-Pacific location offers seamless market access to Asia, Europe, and North America.

Let’s Propel Discovery—Together

From green-field builds to capacity expansions and collaborative labs, our team stands ready to make your Australia strategy seamless. Connect with us today to see how we can power your next breakthrough.